Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 7Unknown 4Terminated 3Withdrawn 2Recruiting 1Not yet recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 723Neoplasms 461Prostatic Neoplasms 398Carcinoma, Non-Small-Cell Lung 388Lung Neoplasms 311Leukemia, Myeloid, Acute 301Multiple Myeloma 270Colorectal Neoplasms 243Neoplasm Metastasis 240Pancreatic Neoplasms 238Leukemia 235Melanoma 217Lymphoma 213Precursor Cell Lymphoblastic Leukemia-Lymphoma 204Brain Neoplasms 195Recurrence 178Head and Neck Neoplasms 177Lymphoma, Non-Hodgkin 174Myelodysplastic Syndromes 168Leukemia, Lymphocytic, Chronic, B-Cell 168Ovarian Neoplasms 160Carcinoma, Hepatocellular 154Glioblastoma 149Carcinoma, Renal Cell 137Rectal Neoplasms 134Colonic Neoplasms 129Lymphoma, Large B-Cell, Diffuse 125Lymphoma, Follicular 125Hodgkin Disease 116Squamous Cell Carcinoma of Head and Neck 109

Interventions

benralizumab 1Fulvestrant 1Fibroblast Growth Factor 7 1Alpelisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × OTHER × Exanthema × Clear all
NCT05966584 2024-08-29

A Study to Prevent Rash in People Starting Alpelisib for the Treatment of Breast Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Terminated
1 enrolled 5 charts
Breast

Breast Neoplasms, Exanthema

NCT01466504 2013-04-15

Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin

Dartmouth-Hitchcock Medical Center

Terminated
4 enrolled
GastrointestinalGenitourinary

Ectrodactyly, Ectodermal Dysplasia, and Cleft Lip-Palate Syndrome 3, Carcinoma, Renal Cell, Exanthema, Carcinoma, Hepatocellular, Colorectal Neoplasms

NCT00610818 2008-02-08

Palifermin

McGill University Health Centre/Research Institute of the McGill University Health Centre

Terminated
7 enrolled

Exanthema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡